PAX Financial Group’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
PAX Financial Group's BIIB Position: Q4 2024 in Review
PAX Financial Group sold out of Biogen (BIIB) in Q4 2024, closing a stake of 1,963 shares — an estimated $381K sold.
PAX Financial Group first reported a position in BIIB in Q4 2019 and held it in 20 quarters. The position peaked at $946K in Q2 2021. 876 funds tracked by Wall St. Rank hold BIIB as of Q4 2024.
- PAX Financial Group reported no remaining Biogen position as of Q4 2024 after selling out during the quarter.
- PAX Financial Group sold 1,963 Biogen shares in Q4 2024, an estimated $381K.
- PAX Financial Group first reported a position in Biogen in Q4 2019 and held it in 20 quarters.
- PAX Financial Group's Biogen position peaked at $946K in Q2 2021.
- 876 funds tracked by Wall St. Rank held Biogen as of Q4 2024.
Based on PAX Financial Group's 13F filing for Q4 2024, filed 12 Feb 2025.